Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (148)	5/19/1998 7:28:00 PM
From: Sigmund	Read Replies (1) of 178

Anyone home? There seems to be a lot of people bailing from this stock. Perhaps that will be good news if the company gets its act together and makes some sales. Then the price would be able to go up without having all of this overhang. Obviously this attempt to impress the analysts failed miserably. Perhaps NPTH will realize that the only way out for them is to actually obtain customers for their system. A couple of announcements about sales would change the dynamics totally. Excluding personalities, I think their biggest problem now is pricing algorithms. They need to price the machine in a way that both their price and value to the customer is consistant with the sort rate. With a 25% sort rate they need a lower price which can go up if and when they get approval for a higher sort rate. This would create a win/win situation for NPTH and the labs. But this concept may be too complex for the NPTH leadership. Hopefully the new hot shot salespeople will be able to convince the company that they need a flexible pricing algorithm. But perhaps just bringing up that subject is grounds for dismissal.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next